Scored from its own price history. Depth shows the figure.
Unlock the score+28.6%
$298.85 to $384.39
since July
Low
Under 28% annualised volatility
This company is scored. Depth shows the figure on every US-listed company.
Risk band Low, from realised volatility.
Three measurements taken from this listing's own price history, each mapped onto 0–100 and then weighted:
70 and above reads Strong, 50–69 Mixed, below 50 Weak.
It is not an analyst rating, not a valuation, and not a recommendation to buy or sell. It describes what the price has already done.
—
Price to earnings, not reported
| Fiscal year ending | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 |
|---|---|---|---|---|
| Revenue | ▮▮▮.▮ | ▮▮▮.▮ | ▮▮▮.▮ | ▮▮▮.▮ |
| Revenue growth | ▮▮▮.▮ | ▮▮▮.▮ | ▮▮▮.▮ | ▮▮▮.▮ |
| Net income | ▮▮▮.▮ | ▮▮▮.▮ | ▮▮▮.▮ | ▮▮▮.▮ |
| Net margin | ▮▮▮.▮ | ▮▮▮.▮ | ▮▮▮.▮ | ▮▮▮.▮ |
| Earnings per share | ▮▮▮.▮ | ▮▮▮.▮ | ▮▮▮.▮ | ▮▮▮.▮ |
| Operating cash flow | ▮▮▮.▮ | ▮▮▮.▮ | ▮▮▮.▮ | ▮▮▮.▮ |
Verified analyst coverage for MSGS.
Nasdaq/TipRanks does not currently provide enough legitimate analyst targets for MSGS. Venuedepth will not invent a bearish, average or bullish target.
Checked against the same verified provider used for covered stocksNo coverage
No broker coverage found
—
No published target